Biotech Clinical Trials

What Are Biotech Clinical Trials? Biotech clinical trials are the studies a biotechnology company runs on an investigational drug, biologic, or gene therapy to generate the safety and efficacy data required for regulatory approval. These trials begin with preclinical lab and animal research, move into an Investigational New Drug (IND) application with the FDA, and then proceed through a series of human trial phases, each designed to answer a different question about the treatment. Because the products being tested are new drugs rather than established categories like supplements or cosmetics, biotech clinical trials carry a much higher regulatory bar and a correspondingly longer timeline before anything can reach the market. How Do Biotech Clinical Trials Differ From Consumer Health Studies? Biotech clinical trials and the consumer health studies used by supplement, skincare, and CPG brands both generate evidence about a product's effects, but they operate under very different regulatory frameworks and stakes. A biotech clinical trial is working toward FDA drug approval, which requires proving both safety and efficacy through a defined phase structure before the product can be sold at all, while a consumer health study is typically substantiating a specific marketing claim for a product that's already legally on the market. This distinction matters for brands: a supplement or skincare company doesn't need to replicate a full biotech trial program to generate credible evidence, but it does need research rigorous enough to hold up if a claim is challenged. What Are the Phases of a Biotech Clinical Trial? Biotech clinical trials generally move through the same phase structure covered in phases of clinical trials: Phase I tests safety and dosage in a small group of healthy volunteers, Phase II expands testing to a larger patient group to evaluate efficacy and side effects, and Phase III enrolls an even larger population to confirm effectiveness and monitor safety before an approval submission. Some companies also conduct Phase IV studies after approval to track long-term outcomes in the general population. Each phase requires its own regulatory clearance to proceed, which is part of why the full biotech trial process from IND filing to approval commonly takes several years. Why Do Biotech Clinical Trials Take Longer Than Consumer Health Studies? Biotech clinical trials take longer than consumer health studies because they're evaluating an unapproved drug or therapy where the primary concern is patient safety, which requires extensive monitoring, larger sample sizes, and sequential regulatory sign-off at every phase. A consumer health study testing an already-marketed supplement or skincare product, by contrast, is usually measuring a narrower outcome, like skin hydration or a wellness benefit, on a product that's already considered safe for consumer use. This difference in regulatory purpose is why a biotech trial program can take a decade or more, while a consumer health study substantiating a specific claim might be completed in a matter of weeks or months. Common Examples of Biotech Clinical Trials A biotech company runs a Phase I trial to establish the safety and dosing range of a new gene therapy in healthy volunteers.A pharmaceutical company conducts a Phase III trial across multiple sites to confirm a drug's efficacy before submitting for FDA approval.A biotech startup partners with a contract research organization to manage the regulatory and logistical demands of a multi-phase trial.A company runs a Phase IV post-market study to monitor an approved drug's long-term safety profile in a broader patient population. What Biotech Clinical Trials Mean for Your Brand Understanding how biotech clinical trials work helps consumer health and CPG brands see where their own research fits on a very different spectrum: while a biotech company is building the evidence needed to bring an entirely new drug to market, a supplement or skincare brand is typically generating evidence to support a specific claim about a product that's already available for sale. That distinction shapes expectations around timeline, cost, and design, and it's worth keeping in mind when a brand is deciding how much rigor its own research program actually needs. Frequently Asked Questions What are biotech clinical trials? Biotech clinical trials are the multi-phase studies biotechnology and pharmaceutical companies run to test a new drug, biologic, or therapy's safety and efficacy for FDA approval. How many phases do biotech clinical trials go through? Biotech clinical trials typically go through three phases before approval, Phase I for safety and dosing, Phase II for efficacy and side effects, and Phase III for large-scale confirmation, with some companies conducting a Phase IV study after approval. How do biotech clinical trials differ from consumer health research? Biotech clinical trials work toward FDA drug approval for a product not yet on the market, while consumer health research typically substantiates a specific claim for a product that's already legally available for sale. Why do biotech clinical trials take so long to complete? Biotech clinical trials take a long time because they involve extensive safety monitoring, large sample sizes, and sequential regulatory approval at each phase before a drug can reach the market. Do consumer health brands need to run biotech-style clinical trials? Consumer health brands generally don't need biotech-style clinical trials, since their products are already legally marketable, but they do need research rigorous enough to support any specific claim they make. What happens after a biotech clinical trial program is complete? After a biotech clinical trial program is complete, the company submits its data to the FDA for approval review, and if approved, the drug can be marketed, sometimes alongside ongoing Phase IV monitoring. Ready to build the right level of research rigor for your product? Talk to Citruslabs.